BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37914569)

  • 21. Application of extracellular vesicles in the diagnosis and treatment of prostate cancer: Implications for clinical practice.
    Oey O; Ghaffari M; Li JJ; Hosseini-Beheshti E
    Crit Rev Oncol Hematol; 2021 Nov; 167():103495. PubMed ID: 34655743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis.
    Pang B; Zhu Y; Ni J; Thompson J; Malouf D; Bucci J; Graham P; Li Y
    Theranostics; 2020; 10(5):2309-2326. PubMed ID: 32089744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating microRNAs as novel biomarkers in the diagnosis of prostate cancer: a systematic review and meta-analysis.
    Yin C; Fang C; Weng H; Yuan C; Wang F
    Int Urol Nephrol; 2016 Jul; 48(7):1087-95. PubMed ID: 27068818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA-based biomarkers for the diagnosis, prognosis, and therapeutic response monitoring of prostate cancer.
    Bae J; Yang SH; Kim A; Kim HG
    Urol Oncol; 2022 Mar; 40(3):105.e1-105.e10. PubMed ID: 34952790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Throughput Isolation and Data Independent Acquisition Mass Spectrometry (DIA-MS) of Urinary Extracellular Vesicles to Improve Prostate Cancer Diagnosis.
    Zhang H; Zhang GY; Su WC; Chen YT; Liu YF; Wei D; Zhang YX; Tang QY; Liu YX; Wang SZ; Li WC; Wesselius A; Zeegers MP; Zhang ZY; Gu YH; Tao WA; Yu EY
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate-specific extracellular vesicles as a novel biomarker in human prostate cancer.
    Park YH; Shin HW; Jung AR; Kwon OS; Choi YJ; Park J; Lee JY
    Sci Rep; 2016 Aug; 6():30386. PubMed ID: 27503267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs in Parkinson's disease: a systematic review and diagnostic accuracy meta-analysis.
    Guévremont D; Roy J; Cutfield NJ; Williams JM
    Sci Rep; 2023 Sep; 13(1):16272. PubMed ID: 37770507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A panel of five circulating microRNAs as potential biomarkers for prostate cancer.
    Chen ZH; Zhang GL; Li HR; Luo JD; Li ZX; Chen GM; Yang J
    Prostate; 2012 Sep; 72(13):1443-52. PubMed ID: 22298030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis.
    Zhang WT; Zhang GX; Zhao RZ; Gao SS
    Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.
    Kawada T; Yanagisawa T; Rajwa P; Sari Motlagh R; Mostafaei H; Quhal F; Laukhtina E; Aydh A; König F; Pallauf M; Pradere B; Ceci F; Baltzer PAT; Hacker M; Rasul S; Karakiewicz PI; Araki M; Nasu Y; Shariat SF
    Eur Urol Oncol; 2022 Aug; 5(4):390-400. PubMed ID: 35715320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood biomarkers for the non-invasive diagnosis of endometriosis.
    Nisenblat V; Bossuyt PM; Shaikh R; Farquhar C; Jordan V; Scheffers CS; Mol BW; Johnson N; Hull ML
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD012179. PubMed ID: 27132058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular Vesicle Surface Markers as a Diagnostic Tool in Transient Ischemic Attacks.
    Burrello J; Bianco G; Burrello A; Manno C; Maulucci F; Pileggi M; Nannoni S; Michel P; Bolis S; Melli G; Vassalli G; Albers GW; Cianfoni A; Barile L; Cereda CW
    Stroke; 2021 Oct; 52(10):3335-3347. PubMed ID: 34344167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A New Approach for Prostate Cancer Diagnosis by miRNA Profiling of Prostate-Derived Plasma Small Extracellular Vesicles.
    Zabegina L; Nazarova I; Nikiforova N; Slyusarenko M; Sidina E; Knyazeva M; Tsyrlina E; Novikov S; Reva S; Malek A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An integrated workflow for biomarker development using microRNAs in extracellular vesicles for cancer precision medicine.
    Chen Y; Wu T; Zhu Z; Huang H; Zhang L; Goel A; Yang M; Wang X
    Semin Cancer Biol; 2021 Sep; 74():134-155. PubMed ID: 33766650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of microRNAs as novel biomarkers for glioma detection: a meta-analysis based on 11 articles.
    Qu S; Guan J; Liu Y
    J Neurol Sci; 2015 Jan; 348(1-2):181-7. PubMed ID: 25510379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular vesicle-associated miRNAs in ovarian cancer - design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistance.
    Kuhlmann JD; Chebouti I; Kimmig R; Buderath P; Reuter M; Puppel SH; Wimberger P; Kasimir-Bauer S
    Clin Chem Lab Med; 2019 Jun; 57(7):1053-1062. PubMed ID: 30422797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the TMPRSS2:ERG fusion for the detection of prostate cancer: a systematic review and meta-analysis.
    Yao Y; Wang H; Li B; Tang Y
    Tumour Biol; 2014 Mar; 35(3):2157-66. PubMed ID: 24142545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymer-Based Precipitation of Extracellular Vesicular miRNAs from Serum Improve Gastric Cancer miRNA Biomarker Performance.
    Chung KY; Quek JM; Neo SH; Too HP
    J Mol Diagn; 2020 May; 22(5):610-618. PubMed ID: 32151712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review and meta-analysis of miRNAs for the detection of cervical cancer.
    Hillyar CR; Kanabar SS; Pufal KR; Saw Hee JL; Lawson AW; Mohamed Y; Jasim D; Reed L; Rallis KS; Nibber A
    Epigenomics; 2023 May; 15(10):593-613. PubMed ID: 37535320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical analysis of EV-Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy.
    Fairey A; Paproski RJ; Pink D; Sosnowski DL; Vasquez C; Donnelly B; Hyndman E; Aprikian A; Kinnaird A; Beatty PH; Lewis JD
    Cancer Med; 2023 Aug; 12(15):15797-15808. PubMed ID: 37329212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.